SynteractHCR Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:SynteractHCR Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013531
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SynteractHCR Inc (SynteractHCR), a subsidiary of Amulet Capital Partners LP is a contract research organization that offers clinical trials support services. The organization provides phase I – IV clinical development services, clinical services, vendor management, study document development, project management, risk mitigation and management, and clinical trial management system. It offers medical and regulatory affair services; clinical monitoring and site management; clinical data management, training, feasibility studies, patient diaries, treatment kit assignment and re-supply; medical writing and biostatistical services. SynteractHCR caters to therapeutic areas of cardiovascular, oncology, neurology, pain, psychiatry, endocrinology, immunotherapy, ophthalmology, infectious disease and respiratory. The organization serves pharmaceutical, biotechnology and medical device companies in different phases of clinical development. It operates in the US, Austria, Belgium, the Czech Republic, Denmark, Germany, France, Italy, Poland, Ukraine, Spain, Russia, Sweden and the UK. SynteractHCR is headquartered in Carlsbad, California, the US.

SynteractHCR Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SynteractHCR Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SynteractHCR Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SynteractHCR Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SynteractHCR Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
SynteractHCR Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
SynteractHCR Inc, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Amulet Capital Partners Acquires SynteractHCR 10
Partnerships 11
SynteractHCR and GOG Foundation Enter into Agreement 11
Acquisition 12
Synteract Completes Acquisition Of Harrison Clinical Research To Form SynteractHCR 12
SynteractHCR Inc – Key Competitors 14
SynteractHCR Inc – Key Employees 15
SynteractHCR Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Corporate Communications 18
Oct 25, 2017: CRO Industry Veteran John Potthoff Joins SynteractHCR Board of Directors 18
Aug 10, 2017: SynteractHCR Announces New Chief Medical Officer Dr. Frank Santoro 19
Jul 17, 2017: SynteractHCR Names Steve Powell as Chief Executive Officer 20
Apr 19, 2017: SynteractHCR Adds Another Three Senior Executives To Management Team With Both U.S. and International Clinical Trials Operations Experience 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
SynteractHCR Inc, Pharmaceuticals & Healthcare, Key Facts 2
SynteractHCR Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SynteractHCR Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SynteractHCR Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SynteractHCR Inc, Deals By Therapy Area, 2011 to YTD 2017 8
SynteractHCR Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Amulet Capital Partners Acquires SynteractHCR 10
SynteractHCR and GOG Foundation Enter into Agreement 11
Synteract Completes Acquisition Of Harrison Clinical Research To Form SynteractHCR 12
SynteractHCR Inc, Key Competitors 14
SynteractHCR Inc, Key Employees 15
SynteractHCR Inc, Other Locations 16
SynteractHCR Inc, Subsidiaries 16

★海外企業調査レポート[SynteractHCR Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Halliburton Co (HAL)-石油・ガス分野:企業M&A・提携分析
    Summary Halliburton Company (Halliburton) is an oilfield services company. The company serves the upstream oil and gas industry throughout the lifecycle of the reservoir, from identifying hydrocarbons and managing geological data, to drilling and formation evaluation, well construction and completio …
  • OUE Ltd:企業の戦略・SWOT・財務情報
    OUE Ltd - Strategy, SWOT and Corporate Finance Report Summary OUE Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Novita Healthcare Ltd (NHL):製薬・医療:M&Aディール及び事業提携情報
    Summary Novita Healthcare Ltd (Novita Healthcare), formerly Avexa Ltd is a medical technology company that focuses on the measurement and treatment of attention difficulties in early childhood. The company operates through its subsidiary The Tali technology, which is developing a tablet based softwa …
  • Meridian Energy Ltd (MEL)-エネルギー分野:企業M&A・提携分析
    Summary Meridian Energy Ltd (Meridian Energy) is a state-owned energy utility that generates, trades and retails electricity. It utilizes renewable energy sources such as wind and water for generation of electricity. It also procures electricity from the wholesale electricity market. The company sup …
  • Liberty Star Uranium & Metals Corp (LBSR):企業の財務・戦略的SWOT分析
    Summary Liberty Star Uranium & Metals Corp (Liberty Star), formerly Liberty Star Gold Corp is a mining and mineral exploration and development company that offers mineral resources. The company offers acquisition, exploration, operations, management, mining, production, and development of gold, copp …
  • Tarveda Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tarveda Therapeutics Inc (Tarveda), formerly Blend Therapeutics Inc is a clinical stage biopharmaceutical company that discovers and develops miniaturized novel biologic drug conjugates. The company develops targeted anti-cancer medicines for advancing the treatment for solid tumors. Its pip …
  • PEP-Therapy SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary PEP-Therapy SAS (PEP-Therapy) is a medical biotechnology company that develops targeted therapies for the treatment of cancer. The company develops cell penetrating and interfering peptides for the intracellular delivery of targeted therapies. Its pipeline products include PEP-010. PEP-Thera …
  • UCB SA (UCB):企業の財務・戦略的SWOT分析
    UCB SA (UCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Delcath Systems Inc (DCTH):医療機器:M&Aディール及び事業提携情報
    Summary Delcath Systems Inc (Delcath) specializes in developing percutaneous perfusion technologies to treat primary and metastatic liver cancers. Its patented drug delivery platform delivers ultra-high doses of anti-cancer drugs to the liver, while preventing them from entering the patient's bloods …
  • Aviakompaniya Sibir” OAO (P):企業の戦略・SWOT・財務情報
    Aviakompaniya Sibir'' OAO (P) - Strategy, SWOT and Corporate Finance Report Summary Aviakompaniya Sibir'' OAO (P) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Yamada Denki Co Ltd:企業の戦略・SWOT・財務分析
    Yamada Denki Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yamada Denki Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Roust Corporation:企業のM&A・事業提携・投資動向
    Roust Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Roust Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Ricardo plc:企業の戦略・SWOT・財務情報
    Ricardo plc - Strategy, SWOT and Corporate Finance Report Summary Ricardo plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Energinet.dk:企業の戦略的SWOT分析
    Energinet.dk - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Peco Energy Company:電力:M&Aディール及び事業提携情報
    Summary PECO Energy Company (PECO), a subsidiary of Exelon Corporation, is a public utility that purchases and sells electricity and gas, and provides electricity transmission and distribution, and gas distribution services. It supplies electricity and gas to residential, commercial, and industrial …
  • Tribune Media Company:企業の戦略・SWOT・財務分析
    Tribune Media Company - Strategy, SWOT and Corporate Finance Report Summary Tribune Media Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Mitsubishi Logistics Corporation (9301):企業の財務・戦略的SWOT分析
    Mitsubishi Logistics Corporation (9301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Standard Chartered Bank – India Branches:企業の戦略・SWOT・財務情報
    Standard Chartered Bank – India Branches - Strategy, SWOT and Corporate Finance Report Summary Standard Chartered Bank – India Branches - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Tung Lok Restaurants (2000) Ltd.:企業の戦略・SWOT・財務情報
    Tung Lok Restaurants (2000) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tung Lok Restaurants (2000) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • KBC Group NV:企業のM&A・事業提携・投資動向
    KBC Group NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KBC Group NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆